Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ISPR
ISPR logo

ISPR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Ispire Technology Inc (ISPR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.830
1 Day change
-2.66%
52 Week Range
4.700
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Ispire Technology Inc (ISPR) is not a good buy for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of positive financial performance, absence of significant trading signals, and no recent positive catalysts make this stock unsuitable for long-term investment at this time.

Technical Analysis

The MACD is slightly positive and expanding, indicating mild bullish momentum. However, RSI is neutral at 47.945, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at $1.646 and resistance at $2.034. Overall, technical indicators suggest a weak trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a lack of bearish sentiment, but the overall low options activity and volume suggest limited interest in the stock.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
3

Positive Catalysts

  • No positive news or catalysts in the recent week. The AI Stock Picker and SwingMax signals are absent, and there is no recent congress trading data.

Neutral/Negative Catalysts

  • Gross margin also decreased by 7.20% YoY. Additionally, hedge funds and insiders are neutral, with no significant trading trends.

Financial Performance

In Q2 2026, the company reported a significant decline in revenue (-51.50% YoY), net income (-17.45% YoY), and EPS (-14.29% YoY). Gross margin also dropped to 17.13%, down 7.20% YoY. These metrics indicate a struggling financial position.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for ISPR. The lack of coverage suggests limited interest from Wall Street analysts.

Wall Street analysts forecast ISPR stock price to rise
1 Analyst Rating
Wall Street analysts forecast ISPR stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.880
sliders
Low
6.5
Averages
6.5
High
6.5
Current: 1.880
sliders
Low
6.5
Averages
6.5
High
6.5
Roth Capital
Buy
downgrade
$9
AI Analysis
2025-05-15
Reason
Roth Capital
Price Target
$9
AI Analysis
2025-05-15
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Ispire Technology to $7.50 from $9 and keeps a Buy rating on the shares. The company's Q2 results were "tempered" as shipment timing on its U.K. supply agreement is being pushed into fiscal Q4 and given that Chinese New Year seasonality and tariffs are also impacting order timing, the analyst tells investors in a research note. An FDA decision in the coming months should provide greater future visibility around licensing opportunities, the firm adds.

People Also Watch